课题基金 / 基金详情

Molecular base of the defenses against infection by IgM and IgA

Molecular base of the defenses against infection by IgM and IgA
IgM 和 IgA 感染防御的分子基础
批准号:
16017215
负责人:
SHIBUYA Akira
金额:
$9.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

SHIBUYA Akira的其他基金

相关文献

中文摘要
翻译
IgM通过启动经典的补体级联反应在天然免疫中起关键作用。近年来,一种新的IgM和伊加Fc受体(Fcα/μR)被克隆,但其在IgM介导的免疫中的作用尚不清楚。在这里,我们发现边缘区B(MZ B)细胞和滤泡树突状细胞(FDC)优先表达Fcα/μR。在Fcα/μ R缺陷小鼠中,尽管对TD抗原的GC形成正常,但对TI抗原的GC形成增强,其中B细胞和FDC均参与。抗原-IgM复合物的形成通过IgM-Fcα/μR相互作用减少BCR介导的活化和B细胞的补体依赖性抗原沉积。Fcα/μ R缺陷小鼠显示MZB细胞和FDC的抗原保留增强,淋巴器官中的CXCL 13表达响应于TI抗原。此外,在Fcα/μ R缺陷小鼠中,TI抗原诱导的GC形成导致IgG 3的亲和力成熟。消除补体途径完全减弱这些表型。总体而言,Fcα/μR可能通过与补体级联反应相互作用,对IgM介导的抗TI抗原免疫应答发挥微调机制。
英文摘要
IgM plays pivotal role in innate immunity by initiating classical complement cascade. Recently, an novel Fc receptor for IgM and IgA, Fcα/μR, was finaly cloned, but its involvement in IgM-mediated immunity was unclear. Here, we show that marginal zone B (MZB) cells and follicular dendritic cells (FDC) preferentially express Fcα/μR. In Fcα/μR-deficient mice, although GC formation against TD antigen was normal, that against TI antigen was enhanced, in which both B cells and FDC were involved. Formation of antigen-IgM complex decreased BCR-mediated activation and complement dependent antigen deposition of B cells via IgM-Fcα/μR interaction. Fcα/μR-deficient mice showed enhanced antigen retention by MZB cells and FDC, and CXCL13 expression in lymphoid organ in response to TI antigen. Moreover, TI antigen induced GC formation in Fcα/μR-deficient mice result in the affinity maturation of IgG3. Abrogation of complement pathway completely attenuated these phenotypes. Collectively, Fcα/μR may exert fine-tuning mechanism of IgM-mediated immune responses against TI antigens by interacting with the complement cascades.
期刊论文(37)
专著(0)
科研奖励(0)
会议论文
Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophic leukemia RBL-2H3.
MAIR-1的残基258和270处的酪氨酸对碱性白血病RBL-2H3脱粒的抑制作用的需要。
DOI: --
发表时间: 2005
期刊: International Immunology 17
影响因子: --
作者: [Wachino J, Yamane K, Shibayama K, Kurokawa H, Shibata N, Suzuki S, Doi Y, Kimura K, Ike Y, Arakawa Y, Okoshi Y et al.]
通讯作者: Okoshi Y et al.
Successful gene transfer into human CD4 positive T cells mediated by lentiviral vectors.
由慢病毒载体介导成功地将基因转移到人类 CD4 阳性 T 细胞中。
DOI: --
发表时间: 2004
期刊: Immunology 12
影响因子: --
作者: [Shibuya K, et al.]
通讯作者: et al.
DOI: --
发表时间: 2004
期刊: Journal of immunology
影响因子: 4.4
作者: [Toru Kimura;Yukio Ishii;Y. Morishima;A. Shibuya;K. Shibuya;M. Taniguchi;M. Mochizuki;A. Hegab;T. Sakamoto;A. Nomura;K. Sekizawa]
通讯作者: Toru Kimura;Yukio Ishii;Y. Morishima;A. Shibuya;K. Shibuya;M. Taniguchi;M. Mochizuki;A. Hegab;T. Sakamoto;A. Nomura;K. Sekizawa
DOI: 10.1111/j.1365-2567.2006.02361.x
发表时间: 2006-06-01
期刊: IMMUNOLOGY
影响因子: 6.4
作者: [Kai, Hirayasu, Shibuya, Kazuko, Shibuya, Akira]
通讯作者: Shibuya, Akira
共 16 条
    Development of the therapy for allergic airway hypersensitivity by using a phospholipid liposome
    • 批准号:
      16K15455
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2016
    • 负责人:
      SHIBUYA Akira
    • 依托单位:
    The immunopathological study on leukocyte adhesion molecule DNAM-1 (CD226)
    • 批准号:
      21249026
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.87万
    • 财政年份:
      2009
    • 负责人:
      SHIBUYA Akira
    • 依托单位:
    Development of immunotherapy for DNAM-1 as a molecular target in graft-versus-host disease
    • 批准号:
      19390257
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2007
    • 负责人:
      SHIBUYA Akira
    • 依托单位:
    Analysis of Mucosal Immunity by the Fc receptor for IgA and IgM
    • 批准号:
      14207024
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $27.62万
    • 财政年份:
      2002
    • 负责人:
      SHIBUYA Akira
    • 依托单位: